TrialBMC cancer2012

Phase I/IIa study of intratumoral/intracerebral or intravenous/intracerebral administration of Parvovirus H-1 (ParvOryx) in patients with progressive primary or recurrent glioblastoma multiforme: ParvOryx01 protocol.

Karsten Geletneky et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.